Nirmatrelvir/Ritonavir (Paxlovid)
Treatment for Long COVID
Effectiveness
50%
Safety Score
65%
Clinical Trials
9
Participants
7.5K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
65
DangerousModerateSafe
Treatment Details
0
Nirmatrelvir/Ritonavir (Paxlovid) Outcomes
for Long COVID
Efficacy Outcomes
Overall Effectiveness
+50%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
3 active trials recruiting for Nirmatrelvir/Ritonavir (Paxlovid) in Long COVID
Antiviral Strategies in the Prevention of Long-term Cardiovascular Outcomes Following COVID-19: The paxloviD/Remdesivir Effectiveness For the prEvention of loNg coviD Clinical Trial
NCT06792214RECRUITINGPHASE4
118 participants
INTERVENTIONAL
Kingston, Canada +3 more
Started: Jan 3, 2025
PAxlovid loNg cOvid-19 pRevention triAl With recruitMent In the Community in Norway
NCT05852873ACTIVE NOT RECRUITINGPHASE3
2K participants
INTERVENTIONAL
Bergen, Norway
Started: May 12, 2023
Covid-19 Long Haul Preventative and Health Promotion Care Clinical Trial Acceleration Program.
NCT06441955RECRUITINGPHASE4
100 participants
INTERVENTIONAL
Bethesda, United States
Started: Mar 1, 2024
Completed Clinical Trials
6 completed trials for Nirmatrelvir/Ritonavir (Paxlovid) in Long COVID
RECOVER-VITAL: Platform Protocol, Appendix to Measure the Effects of Paxlovid on Long COVID Symptoms
NCT05965726COMPLETEDPHASE2
964 participants
INTERVENTIONAL
Durham, United States
Started: Jul 26, 2023
A Decentralized, Randomized Phase 2 Efficacy and Safety Study of Nirmatrelvir/Ritonavir in Adults with Long COVID.
NCT05668091COMPLETEDPHASE2
100 participants
INTERVENTIONAL
New Haven, United States
Started: Apr 14, 2023
ImPROving Quality of LIFe in the Long COVID Patient
NCT05823896COMPLETEDPHASE2
219 participants
INTERVENTIONAL
Stockholm, Sweden
Started: May 1, 2023
Paxlovid for Treatment of Long Covid
NCT05576662COMPLETEDPHASE2
168 participants
INTERVENTIONAL
Stanford, United States
Started: Nov 8, 2022
RECOVER-VITAL: Platform Protocol to Measure the Effects of Antiviral Therapies on Long COVID Symptoms
NCT05595369COMPLETEDPHASE2
963 participants
INTERVENTIONAL
Birmingham, United States +68 more
Started: Jul 26, 2023
A Study to Understand How the Use of Paxlovid Affected Healthcare Use in People With Pre-existing Conditions.
NCT07090486COMPLETED
14K participants
OBSERVATIONAL
New York, United States
Started: Apr 15, 2025